These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26228058)

  • 21. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 22. Loss of ITM2A, a novel tumor suppressor of ovarian cancer through G2/M cell cycle arrest, is a poor prognostic factor of epithelial ovarian cancer.
    Nguyen TM; Shin IW; Lee TJ; Park J; Kim JH; Park MS; Lee EJ
    Gynecol Oncol; 2016 Mar; 140(3):545-53. PubMed ID: 26691219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression profiles as prognostic markers in women with ovarian cancer.
    Jochumsen KM; Tan Q; Høgdall EV; Høgdall C; Kjaer SK; Blaakaer J; Kruse TA; Mogensen O
    Int J Gynecol Cancer; 2009 Oct; 19(7):1205-13. PubMed ID: 19823056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations.
    Teng Y; Su X; Zhang X; Zhang Y; Li C; Niu W; Liu C; Qu K
    Oncotarget; 2016 Dec; 7(49):81621-81633. PubMed ID: 27835595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spy1 participates in the proliferation and apoptosis of epithelial ovarian cancer.
    Lu S; Liu R; Su M; Wei Y; Yang S; He S; Wang X; Qiang F; Chen C; Zhao S; Zhang W; Xu P; Mao G
    J Mol Histol; 2016 Feb; 47(1):47-57. PubMed ID: 26644004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modelling genetic and clinical heterogeneity in epithelial ovarian cancers.
    Lawrenson K; Sproul D; Grun B; Notaridou M; Benjamin E; Jacobs IJ; Dafou D; Sims AH; Gayther SA
    Carcinogenesis; 2011 Oct; 32(10):1540-9. PubMed ID: 21859834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. lncRNAs as Novel Indicators of Patients' Prognosis in Stage I Epithelial Ovarian Cancer: A Retrospective and Multicentric Study.
    Martini P; Paracchini L; Caratti G; Mello-Grand M; Fruscio R; Beltrame L; Calura E; Sales G; Ravaggi A; Bignotti E; Odicino FE; Sartori E; Perego P; Katsaros D; Craparotta I; Chiorino G; Cagnin S; Mannarino L; Ceppi L; Mangioni C; Ghimenti C; D'Incalci M; Marchini S; Romualdi C
    Clin Cancer Res; 2017 May; 23(9):2356-2366. PubMed ID: 27827314
    [No Abstract]   [Full Text] [Related]  

  • 28. Epithelial ovarian cancer: the molecular genetics of epithelial ovarian cancer.
    Krzystyniak J; Ceppi L; Dizon DS; Birrer MJ
    Ann Oncol; 2016 Apr; 27 Suppl 1(Suppl 1):i4-i10. PubMed ID: 27141069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico analyses identify gene-sets, associated with clinical outcome in ovarian cancer: role of mitotic kinases.
    Ocaña A; Pérez-Peña J; Alcaraz-Sanabria A; Sánchez-Corrales V; Nieto-Jiménez C; Templeton AJ; Seruga B; Pandiella A; Amir E
    Oncotarget; 2016 Apr; 7(16):22865-72. PubMed ID: 26992217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.
    Sosulski A; Horn H; Zhang L; Coletti C; Vathipadiekal V; Castro CM; Birrer MJ; Nagano O; Saya H; Lage K; Donahoe PK; Pépin D
    PLoS One; 2016; 11(6):e0156595. PubMed ID: 27253518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
    Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
    Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.
    Sun F; Ding W; He JH; Wang XJ; Ma ZB; Li YF
    BMC Cancer; 2015 Oct; 15():746. PubMed ID: 26487491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities.
    Calura E; Fruscio R; Paracchini L; Bignotti E; Ravaggi A; Martini P; Sales G; Beltrame L; Clivio L; Ceppi L; Di Marino M; Fuso Nerini I; Zanotti L; Cavalieri D; Cattoretti G; Perego P; Milani R; Katsaros D; Tognon G; Sartori E; Pecorelli S; Mangioni C; D'Incalci M; Romualdi C; Marchini S
    Clin Cancer Res; 2013 Aug; 19(15):4114-23. PubMed ID: 23766361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening of the residual normal ovarian tissue adjacent to orthotopic epithelial ovarian carcinomas in nude mice.
    Zhu GH; Wang ST; Yao MZ; Cai JH; Chen CY; Yang ZX; Hong L; Yang SY
    Genet Mol Res; 2014 Apr; 13(2):2978-86. PubMed ID: 24782132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CHD5 Downregulation Associated with Poor Prognosis in Epithelial Ovarian Cancer.
    Wong RR; Chan LK; Tsang TP; Lee CW; Cheung TH; Yim SF; Siu NS; Lee SN; Yu MY; Chim SS; Wong YF; Chung TK
    Gynecol Obstet Invest; 2011; 72(3):203-7. PubMed ID: 21860208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Signature for Lymphatic Invasion Associated with Survival of Epithelial Ovarian Cancer.
    Paik ES; Choi HJ; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
    Cancer Res Treat; 2018 Apr; 50(2):461-473. PubMed ID: 28546526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expressions of BCL6 and Lewis y antigen are correlated with high tumor burden and poor prognosis in epithelial ovarian cancer.
    Zhu L; Feng H; Jin S; Tan M; Gao S; Zhuang H; Hu Z; Wang H; Song Z; Lin B
    Tumour Biol; 2017 Jul; 39(7):1010428317711655. PubMed ID: 28671040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the REG4 gene and its encoding product in ovarian epithelial carcinoma.
    Chen S; Gou WF; Zhao S; Niu ZF; Zhao Y; Takano Y; Zheng HC
    BMC Cancer; 2015 Jun; 15():471. PubMed ID: 26077911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of hypoxia-inducible factor 1alpha gene affects the outcome in patients with ovarian cancer.
    Shimogai R; Kigawa J; Itamochi H; Iba T; Kanamori Y; Oishi T; Shimada M; Sato S; Kawaguchi W; Sato S; Terakawa N
    Int J Gynecol Cancer; 2008; 18(3):499-505. PubMed ID: 18476949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated microRNA and mRNA signatures in peripheral blood lymphocytes of familial epithelial ovarian cancer.
    Dou YD; Huang T; Wang Q; Shu X; Zhao SG; Li L; Liu T; Lu G; Chan WY; Liu HB
    Biochem Biophys Res Commun; 2018 Jan; 496(1):191-198. PubMed ID: 29307835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.